FDA Import Refusal AEK-4109787-2/41/1 — Getz Pharma Pakistan
The FDA refused shipment AEK-4109787-2/41/1 from Getz Pharma Pakistan (Pakistan) on Oct 17, 2023. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charges: 118,75
Refusal details
- Date
- Oct 17, 2023
- Country
- Pakistan
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 118,75